Early Life
August Troendle, born January 1, 1956, is a medical doctor who embarked on a career path that blended regulatory oversight, pharmaceutical development, and entrepreneurship. He earned his Medical Degree from the University of Maryland, School of Medicine. His early experience included serving as a Medical Review Officer in the Division of Metabolic and Endocrine Drug Products at the FDA.
Rise to Success
Troendle's career included a stint at Sandoz (Novartis), where he was responsible for the clinical development of lipid-altering agents. Recognizing the need for high-quality clinical research services, he founded Medpace in Cincinnati, Ohio, in 1992. He served as President through July 31, 2021.
Key Business Strategies
Troendle's leadership has been key to Medpace's growth. Medpace offers comprehensive solutions for drug and medical device testing. He owns nearly 20% of Medpace stock. Medpace's 2024 revenues were approximately $2.11 billion.
Philanthropy
August Troendle is recognized for his philanthropy, supporting healthcare initiatives and research endeavors.